Discover the development of a new model to assess drug safety, absorption, methabolism, transport, and permeability.

Compromised intestinal barrier function has been associated with a number of intestinal and systemic diseases, including inflammatory bowel disease (IBD), obesity, metabolic disorders, and graft versus host disease.

X

Have any questions?

contact us